下一个

自动播放

MRD’s Potential Role in Treating Acute Myeloid Leukemia

0 意见 • 07/04/23
分享
嵌入
administrator
administrator
订户
0

Harry Erba, MD, PhD; Alexander E. Perl, MD; Eunice Wang, MD; and Jorge E. Cortes, MD, debate the current value of minimal residual disease testing for therapeutic decision-making in acute myeloid leukemia and identify the needs to be addressed before use in standard practice.

显示更多
0 注释 sort 排序方式
脸书评论

下一个

自动播放